Mammalian peptide transporters (PEPT1 and PEPT2) play a pivotal role in the absorption of small peptides from the intestine and kidney, respectively, and in the disposition and targeting of peptide or mimetic drugs. However, there are few reports on the molecular basis of their regulation, especially in the young. The aim of this study was to determine the developmental expression of intestinal and renal oligopeptide transporters in rats from embryonic to adult ages. Intestinal segments were collected (i.e. duodenum, jejunum, ileum, and colon) along with whole kidney, and their mRNA and protein levels were measured. Expression levels of PEPT1 were maximal 3-5 d after birth in the duodenum, jejunum, and ileum, and then declined rapidly. Expression was increased transiently at d 24, most notably in the ileum. Adult protein levels were approximately 70% of that observed on d 3-5. Significant PEPT1 expression was observed in colon during the first week of life, but levels were undetectable shortly thereafter through adulthood. PEPT1 and PEPT2 expression is less regulated in rat kidney and more pronounced in older animals. Peptide transporters were also present as early as d 20 of fetal life for all tissues tested. These results are unique in providing the developmental expression of peptide transporter mRNA and protein in distinct regions of the small intestine, colon, and kidney in rat. Our findings suggest that intestinal expression of PEPT1 is induced postpartum, possibly by suckling, and again at the time of weaning, and that the colon may participate in peptide transport early in life. Expression and molecular cloning studies have resulted in the identification of two distinct proton-coupled oligopeptide transporters in rabbit (1-3), rat (4 -6), and human (7, 8) (i.e. PEPT1 as low-affinity carrier, PEPT2 as high-affinity carrier). The proteins range in size from 707 to 729 amino acids in various species, with high homology between species for a given transporter (approximately 80%) and less homology between transporters for a given species (approximately 50%). The gene products, as predicted by hydropathy analysis, contain 12 membrane-spanning domains and a large extracellular loop between transmembrane domains 9 and 10. The encoded proteins have a number of potential N-glycosylation as well as protein kinase recognition sites, which suggests that the transporters may be regulated by reversible phosphorylation. More recently, a third peptide transporter, PHT1, was cloned from rat brain (9). Encoding a protein of 572 amino acids, hydropathy analysis predicts the presence of 12 transmembrane domains. There are also multiple N-glycosylation sites in the hydrophilic extracellular loop of PHT1, along with potential sites for protein kinase C-dependent phosphorylation. PHT1 is novel in that it transports histidine, as well as small peptides, with high affinity and in a proton gradient-dependent manner. Although expressed in the brain and eye, PHT1 is not found in the intestine or kidney and shows little homology to P...